Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bilcock, D. T.
Right arrow Articles by Halford, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bilcock, D. T.
Right arrow Articles by Halford, S. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 51, 36379-36386, December 17, 1999


Reactions of Type II Restriction Endonucleases with 8-Base Pair Recognition Sites*

Denzil T. Bilcock, Lucy E. Daniels, Abigail J. Bath, and Stephen E. HalfordDagger

From the Department of Biochemistry, School of Medical Sciences, University of Bristol, University Walk, Bristol BS8 1TD, United Kingdom

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Type II restriction endonucleases usually recognize 4-6-base pair (bp) sites on DNA and cleave each site in a separate reaction. A few type II endonucleases have 8-bp recognition sites, but these seem unsuited for restriction, since their sites are rare on most DNA. Moreover, only one endonuclease that recognizes a target containing 8 bp has been examined to date, and this enzyme, SfiI, needs two copies of this site for its DNA cleavage reaction. In this study, several endonucleases with 8-bp sites were tested on plasmids that have either one or two copies of the relevant sequence to determine if they also need two sites. SgfI, SrfI, FseI, PacI, PmeI, Sse8781I, and SdaI all acted through equal and independent reactions at each site. AscI cleaved the DNA with one site at the same rate as that with two sites but acted processively on the latter. In contrast, SgrAI showed a marked preference for the plasmid with two sites and cleaved both sites on this DNA in a concerted manner, like SfiI. Endonucleases that require two copies of an 8-bp sequence may be widespread in nature, where, despite this seemingly inappropriate requirement, they may function in DNA restriction.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The recognition sequences for the majority of the ~3,000 type II restriction endonucleases identified to date are symmetrical palindromes of DNA, 4-6-bp1-long, although ~20 enzymes of this type recognize 8-bp targets (1). The latter are particularly valuable as tools for the analysis of genomic DNA because they usually cleave DNA into larger DNA fragments than the enzymes cutting at 4- or 6-bp sequences, due to the relative rarity of their sites (2). However, doubts exist over whether a restriction enzyme with an 8-bp site could provide a bacterial cell with an effective defense against foreign DNA (3). Restriction demands at least one recognition site on the incoming DNA, and its efficiency increases with the number of sites (4). The probability of DNA escaping restriction, by being modified at all sites before being cleaved at any one site, declines logarithmically with the number of sites. Yet an 8-bp sequence must occur less frequently on DNA than any 4- or 6-bp element from that sequence, so phage or plasmid DNA may often lack an 8-bp site or contain only a small number of such sites. Hence, if the defense against phage infections by a restriction-modification system confers a selective advantage to a bacterial cell, evolutionary pressures should result in a contraction of the length of the recognition sequence (5).

Most of the current information about the mode of action of type II restriction enzymes derives from a relatively small number of enzymes, almost all of which recognize either a 4- or a 6-bp sequence, such as BamHI, EcoRV, MunI, PvuII, or TaqI (Refs. 6-10, and references therein). In each of these examples, the protein is a dimer of identical subunits that interacts symmetrically with a palindromic DNA sequence, so that the two active sites in the enzyme are positioned on the scissile phosphodiester bonds in each strand. In the presence of Mg2+, the cofactor for DNA cleavage, the two strands are cut in parallel reactions. The cleavage of both strands is normally completed before the enzyme dissociates from the DNA, although, in some instances, the enzyme dissociates after cutting just one strand and then returns to that site to cut the second strand (11). On DNA with multiple sites, these enzymes usually act in a distributive manner at each individual copy of the recognition sequence. However, they sometimes act processively on a DNA with two or more sites. For example, EcoRI can cleave one site, translocate to another site by an intramolecular process, cut that site, and only then leave the DNA (12, 13). Conversely, the restriction enzymes in the type IIe group, such as EcoRII and NaeI, require two copies of their recognition sequence (14, 15). Both EcoRII and NaeI are reported to be homodimeric proteins that have two distinct DNA-binding sites. One binding site has the catalytic functions for DNA cleavage, but this remains inactive unless a second copy of the recognition sequence binds to an allosteric site elsewhere in the dimer (16-18). The DNA at the allosteric site is not cleaved (19, 20).

To date, a reaction mechanism has been established for only one of the type II enzymes that recognizes a site with 8 specified bp: the SfiI endonuclease from Streptomyces fimbriatus (21-27). In contrast to both the orthodox enzymes such as EcoRV and the type IIe enzymes such as EcoRII, SfiI is a tetrameric protein that has two identical binding sites for its palindromic recognition sequence, each presumably made from two subunits. However, SfiI has no activity when only one DNA-binding site is occupied. Instead, it has to bind two copies of its recognition sequence before being able to cleave DNA. The two sites can be in cis, on the same molecule of DNA, or in trans, on separate molecules of DNA. In the former case, SfiI tethers the intervening DNA in a loop, while, in the latter, it bridges the two DNA molecules. As with other proteins that span two sites (28), SfiI prefers sites in cis over sites in trans. It generally cleaves plasmids with two sites more rapidly than plasmids with one site. Moreover, the turnover of SfiI on plasmids with two sites is normally completed by the liberation of DNA cut in both strands at both sites; only a small fraction of the DNA is liberated after cutting just one site. The concerted action of SfiI at two recognition sites is reminiscent of the enzymes that mediate DNA rearrangements by site-specific recombination or transposition (29), but a role for SfiI in re-arrangements has been rejected (30). Like the orthodox restriction enzymes (31), phosphodiester hydrolysis by SfiI inverts the stereoconfiguration of the phosphate, so its reaction cannot involve a covalent enzyme-DNA intermediate (32). Enzymes that catalyze both DNA breakage and religation normally conserve the energy of the phosphodiester bond, a prerequisite for the religation step, by forming a covalent intermediate (29).

In vivo, SfiI can restrict DNA that has two or more SfiI sites, but it is incompetent at restricting DNA with one site (30). The mode of action of SfiI thus exacerbates the doubts over whether an enzyme recognizing an 8-bp sequence could defend a cell against phage or plasmid DNA. However, the recognition sequence for SfiI is unusual (33) in that it contains 8 specified bp but these are interrupted by a unspecified spacer of 5 bp (Table I). Apart from one isoschizomer of SfiI, all of the other type II enzymes that cleave DNA at 8-bp sites recognize uninterrupted sequences of 8 consecutive bp (Table I). Hence, while the type II enzymes with continuous recognition sites of 8 bp might act like SfiI, they may differ from SfiI and behave instead like the orthodox enzymes such as BamHI or EcoRV. These possibilities were examined by assaying several restriction enzymes on plasmids that have either one or two copies of the relevant sequence in order to determine whether they act concertedly at two sites or cleave each site in a separate reaction.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Enzymes-- Restriction endonucleases were purchased from the following suppliers: AscI, FseI, PacI, PmeI, Sse8387I, SacI, SalI, and SphI from New England Biolabs; SgfI from Promega; SrfI from Stratagene; and SdaI from Fermentas; SgrAI from both Roche Molecular Biochemicals and New England Biolabs (with equivalent results). Enzyme concentrations are given in terms of units of enzyme activity, as specified by the supplier. Other enzymes were obtained from New England Biolabs or Roche Molecular Biochemicals.

DNA-- The plasmids pAT153 (34) and pNEB193 (New England Biolabs) have been described before; the latter is identical to pUC19 (35) except for an enlarged multiple cloning site (MCS) with a number of additional restriction sites. Two derivatives of pAT153, pDB7 and pDB8 (Fig. 1a), and one of pNEB193, pAB1 (Fig. 1b), were constructed by standard methods (36). The duplex used in the construction of pDB7 was produced by annealing two 50-base synthetic oligodeoxynucleotides that were complementary to each other except for 4 bases at their 5' termini; the resultant 46-bp duplex had 4-base 5'-extensions that matched an EagI terminus at one end and a StyI terminus at the other (Fig. 1a). The SgrAI site in this duplex had the same sequence as the intrinsic site on pAT153, with respect to both its purine/pyrimidine degeneracies (Table I) and to its flanking sequence for 3 bp on either side. The duplex used in the construction of pDB8 was made by the same procedure; it had the same sequence as the duplex for pDB7, except that it lacked the SgrAI site and its 4-base 5'-extensions matched, respectively, EcoRI and HindIII termini (Fig. 1a). The plasmids were used to transform recA strains of Escherichia coli, either HB101 (36) or ER2238 (37). The transformants were cultured in M9 minimal medium with 1 mCi/liter [methyl-3H]thymidine, and the covalently closed form of the plasmid was purified by density gradient centrifugations (38). The preparations were largely supercoiled monomeric plasmid, with <10% as either dimeric plasmid or nicked open circle DNA.

Assays-- Reactions were carried out at 37 °C in 200-µl volumes and were initiated by adding the restriction enzyme (typically 10 units) to the requisite plasmid (10 or 20 nM) in an appropriate buffer. In the first instance, the buffer used with each enzyme was that advised by the supplier. To test for processivity (12), most enzymes were also examined in modified buffers with elevated ionic strengths. For enzymes where the recommended buffer contains NaCl, the modified buffer had double the concentration of NaCl. Similarly, buffers with KOAc were adjusted to twice the advised level of KOAc. At various times after adding the enzyme, aliquots (15 µl) were removed from the reactions and mixed immediately with 10 µl of an EDTA stop mix (38). The samples were analyzed by electrophoresis through agarose under conditions that separated the supercoiled substrate and each of the various products from the reaction (Fig. 2). The segments of the agarose gel that encompassed the substrate and each product were analyzed individually by scintillation counting to yield the concentration of each form of the DNA at each time point (38). For plasmids with two recognition sites, the two linear DNA fragments (L1 and L2) arising from cleavage at both sites were counted together to obtain a single value for the concentration of doubly cut DNA (L1/2).

Experimental Strategy-- A distinction between the different modes of action seen among the type II restriction enzymes can be made by analyzing the reaction kinetics of the enzyme on two substrates, one with one copy of its recognition sequence and another with two copies.

An orthodox enzyme like EcoRV will cleave a circular DNA with one copy of its recognition site first in one strand, converting the supercoiled (SC) substrate to the nicked open circle (OC) form of the DNA, and then in the second strand to produce the full-length linear (FLL) form (Fig. 2a). However, the hydrolysis of both phosphodiester bonds is often much faster than the dissociation of the cleaved DNA (8, 13, 39). In these cases, the nicked form exists only as a transient enzyme-bound intermediate, and the sole product that accumulates during a steady-state reaction is the FLL form. A SC DNA with two sites will be cleaved by an orthodox enzyme acting distributively first at one site to yield FLL DNA and then at the other site to give two linear fragments, L1 and L2 (Fig. 2b). The reaction on a two-site DNA should therefore follow a sequential A right-arrow B right-arrow C pathway, where the concentration of B first rises and then falls in a manner specified by the relative rates of the A right-arrow B and the B right-arrow C steps and where the formation of C is preceded by a characteristic lag phase (40). If the recognition sites on the one- and two-site substrates are all equal to each other, then the initial rate for the utilization of the SC DNA with one site (v1) should equal that for the utilization of the SC DNA with two sites (v2A), and the latter should also equal the rate for the conversion of the FLL DNA to L1 and L2 (v2B).

A type II restriction enzyme that acts processively on a DNA with multiple sites should also utilize the two-site substrate at the same rate as the one-site substrate. But if the enzyme then travels along the DNA to another site and cuts that site before departing from the DNA, the SC substrate with two sites will be converted quickly to the doubly cut products, without an intervening accumulation of FLL DNA and without a lag phase preceding the formation of L1 and L2. However, the processivity is unlikely to be 100% efficient, and the enzyme will sometimes depart from the DNA before cutting the second site. Nevertheless, processivity will diminish the yield of FLL DNA from the two-site substrate, relative to that from an orthodox enzyme acting distributively. Moreover, the degree of processivity is likely to decrease as the ionic strength of the reaction is increased (12, 13). Hence, an enzyme that acts processively at low ionic strength is likely to act in a distributive manner at high ionic strength.

In contrast, a restriction enzyme that follows the mechanism proposed for the type IIe enzymes will utilize the substrate with two sites more rapidly than that with one site, since the interaction with the second site, which is needed to activate the enzyme, will be aided if this is provided in cis rather than in trans. Having cleaved one site on a two-site substrate, a type IIe enzyme would cleave the residual site at a slow rate, so a large amount of FLL DNA should accumulate during the reaction.

An enzyme that acts concertedly at two recognition sites, like SfiI, would also utilize a two-site plasmid more rapidly than a one-site plasmid. However, in contrast to a type IIe enzyme, a concerted reaction on a two-site plasmid will give directly the final products cut at both sites, L1 and L2. A diminished yield of FLL DNA from a SC DNA with two sites could thus be due to either concerted or processive actions, but these can be distinguished by analyzing the reactions at varied ionic strengths. Both the difference in the reaction rates of SfiI on plasmids with one or two sites and the degree of concertedness on plasmids with two sites depend on the concentration of NaCl in the reaction (22). In reactions lacking NaCl, SfiI cleaves DNA with one site almost as readily as DNA with two sites; under these conditions, the protein binds to its recognition sites with sufficiently high affinity so that even the relatively weak interactions with sites in trans still permit the maximal reaction rate (27). A small amount of salt prevents the interactions in trans, so SfiI reactions on DNA with one site are blocked at lower levels of NaCl than those on DNA with two sites (22). In high salt, SfiI cleaves DNA with two sites much more rapidly than DNA with one site. But the progressive destabilization of the complex of SfiI and two DNA sites with increasing ionic strength results in the progressive liberation of products from the two-site substrate that have been cleaved in three, two, or one phosphodiester bonds in place of the product cleaved at both sites in both strands (25, 26).

The reaction kinetics of a restriction enzyme on one-site and two-site substrates thus provide a diagnostic test for the mode of action of the enzyme; for independent reactions at individual sites, v1 = v2A = v2B; for processive action on a DNA with two sites, v1 = v2A < v2B; for activation by a second site, v1 < v2A v2B; for concerted action at two sites, v1 < v2A < v2B. However, data at one ionic strength that yield a match to one of the above sets of relative values for v1, v2A, and v2B may be insufficient for the diagnosis. An unambiguous distinction between these possibilities requires data at varied ionic strengths.

A meaningful comparison of the activities on one- and two-site substrates requires the following conditions to be met. First, the plasmids must be isolated from recombination-deficient strains to prevent the one-site DNA from recombining to its dimeric form with two sites; recA strains were used here. Second, the DNA sequences flanking each recognition site on the two substrates must all be the same, since restriction activity is often affected by the flanking DNA (41-43); plasmid substrates were designed to meet this requirement (Fig. 1). Third, the two-site substrate must have an appropriate length of DNA between the sites. Lengths of <300 bp may be inappropriate, because DNA looping between closely spaced sites depends on both the helical periodicity and the bending of the intervening DNA (26). Conversely, on linear DNA, the stability of a loop between sites separated by >300 bp decreases as the separation increases, but this effect is largely nullified by DNA supercoiling (28). On SC DNA, increasing the separation of the sites above 400 bp has at most only a marginal effect on loop stability (44, 45). All of the tests described here used SC plasmids with, in the case of the two-site substrates, >500 bp between the sites. Fourth, the reactions must employ lower concentrations of enzyme than substrate. Otherwise, the enzyme may bind independently to each site on the two-site DNA and cleave this DNA at double the rate of the one-site DNA.

This study used commercial preparations of restriction enzymes, whose concentrations were specified in terms of units of activity rather than molarity. Nevertheless, the reactions are likely to have used lower concentrations of enzyme than DNA. For several enzymes, varied numbers of units were added to the reactions, and in all cases, the reaction velocities increased linearly with the number of units (data not shown). This behavior is characteristic of a steady-state reaction with substrate in excess of the enzyme. If the reactions had contained enzyme in excess of substrate, the rates would not have varied with the amount of enzyme. A further concern arises from the use of SC substrates. If an enzyme is more active on SC DNA than on linear DNA (or vice versa), the rate for the conversion of a SC DNA with two sites to the FLL form will differ from that for the subsequent conversion of FLL DNA to L1 and L2. Several of the enzymes were therefore tested on both SC and linear DNA substrates, the latter being generated by cleaving the plasmid with another restriction enzyme; in all cases, the SC and linearized substrates gave the same reaction rates (data not shown).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

SgfI, SrfI, SgrAI, and FseI-- The above strategy was applied first to a set of four enzymes with 8-bp recognition sites: SgfI, SgrAI, SrfI, and FseI. The first three of these were selected because they, like SfiI, are from Streptomyces species (Table I). FseI was chosen because its recognition sequence is the same as that for SfiI except for the absence of the 5-bp interruption in the SfiI site (Table I). Plasmids with one or two recognition sites for each enzyme were constructed from pAT153, which has one site for SgrAI and none for the other enzymes (Fig. 1a). The first construct, pDB7, contains two sites for SgrAI, separated by 571 bp, and one site for the other enzymes. The second, pDB8, contains two sites for SgfI, SrfI, and FseI, separated in each case by 949 bp.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Recognition sequences
The names, the species of origin, and the recognition sequences (1) for all of the restriction enzymes examined here are listed.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 1.   Construction of plasmid substrates. a, the plasmid pAT153 was cleaved with EagI and StyI and ligated to an oligonucleotide duplex whose sequence included individual recognition sites for SgrAI, SgfI, SrfI, and FseI. The resultant plasmid, pDB7, was cleaved with EcoRI and HindIII and ligated to an oligonucleotide duplex whose sequence included individual recognition sites for SgfI, SrfI, and FseI to yield pDB8. The vector, pAT153, has one recognition site for SgrAI; pDB7 has two sites for SgrAI and one each for SgfI, SrfI, and FseI; and pDB8 has two sites for SgfI, SrfI, and FseI. b, the plasmid pNEB193 was cleaved with PvuII, and the fragment spanning the MCS, shown in gray shading, was isolated by electrophoresis and ligated to a second sample of pNEB193 that had been cleaved with SspI. The MCS in pNEB193 has solitary recognition sites for AscI, PacI, PmeI, and Sse8387I (SdaI) and also, not shown, for SacI, SalI, and SphI, while pAB1 has two copies of each of these sites.

For each enzyme, parallel experiments were carried out on the one-site and two-site plasmids. Samples were withdrawn from the reactions at varied times and analyzed by electrophoresis through agarose. Typical gels, from SgfI reactions on pDB7 and pDB8, are shown in Fig. 2, a and b, respectively (others not shown). With both plasmids, the intact SC, the nicked OC, and the FLL forms of the DNA were isolated from each other, as were the fragments produced by cutting both sites on the two-site DNA, L1 and L2. The concentrations of each form of the DNA, at each time point sampled during the reaction, were then determined (Fig. 3). Rates for the utilization of the one- and two-site substrates, v1 and v2A, respectively, were measured from the initial linear decline in the concentration of SC DNA with time, while the rate for the second reaction on the two-site substrate, v2B, was assessed relative to v2A from the time course for the production and decay of the FLL DNA. If v2A = v2B, the maximal amount of FLL DNA produced during the reaction will be 40% of the total DNA, but if the amount of FLL DNA rises to a maximum of >40% of the total DNA, then v2A v2B; conversely, a maximum of <40% indicates that v2A < v2B (modeling not shown).


View larger version (43K):
[in this window]
[in a new window]
 
Fig. 2.   Reactions of a type II endonuclease on plasmids with one or two recognition sites. The reactions contained 50 units·ml-1 SgfI and 20 nM DNA (~95% supercoiled) in 10 mM Tris·HCl (pH 7.9), 100 mM NaCl, 10 mM MgCl2, and 1 mM dithiothreitol, at 37 °C. The DNA in a was pDB7, which has one SgfI site, and the DNA in b was pDB8, which has two SgfI sites. At timed intervals after adding the enzyme, samples from the reactions were quenched with stop mix and analyzed by electrophoresis through agarose. The schematics in both a and b illustrate the various forms of DNA that can exist during these reactions. The agarose gels in both a and b illustrate the separation of these forms of the DNA; the electrophoretic mobility of each form is marked on the right of the gels. The reaction times (0-120 min) are noted as expanding scales above the gels.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 3.   SgfI on plasmids with one or two recognition sites. The reactions of SgfI on pDB7 (which has one SgfI site) (a) or pDB8 (two SgfI sites) (b) that are shown in Fig. 2, a and b, respectively, were analyzed to obtain the concentrations of the following forms of the DNA at each time point during the reaction: , SC; , OC; black-triangle, FLL; down-triangle (only in b), total DNA in the two final products cut at both sites (L1/2). The plasmids were 3H-labeled, and the DNA concentrations were determined by assessing individual segments of the agarose gels (Fig. 2) in a scintillation counter.

The reaction of SgfI on a SC plasmid with one cognate site yielded virtually none of the OC DNA. Instead, almost all of the substrate was converted directly to the FLL product (Fig. 3a). Thus, as with many other restriction enzymes (11), SgfI cuts its recognition site in both strands before dissociating from the DNA. SgfI again yielded virtually none of the OC DNA from the plasmid with two SgfI sites, and the only product formed in significant yield during the initial period of this reaction was FLL DNA; the FLL DNA was subsequently cleaved at the second site to give L1 and L2 (Fig. 3b). Both the initial rise in the concentration of FLL DNA, to a maximum of ~40% of the total DNA, and the lag phase preceding the formation of L1 and L2 denote a sequential A right-arrow B right-arrow C pathway, with equal rates for the A right-arrow B and the B right-arrow C steps. Moreover, the rate at which SgfI utilized the one-site substrate (v1 = 0.41 nM·min-1) equaled that for the utilization of the two-site substrate (v2A = 0.44 nM·min-1). The SgfI endonuclease thus clearly cleaves DNA by means of independent reactions at individual sites.

Unlike SgfI, the SrfI and FseI endonucleases initially generated some OC DNA during their reactions on their one-site and two-site substrates, pDB7 and pDB8, respectively, and only later gave FLL DNA. But like SgfI, the rates at which SrfI and FseI utilized the one-site substrate were the same as those on the two-site substrate, and the two sites in pDB8 were cleaved sequentially at equal rates (data not shown). Thus, both SrfI and FseI also cleave DNA through independent reactions at individual sites. Indeed, the initial liberation of OC DNA during the reactions of these two enzymes indicates that they sometimes dissociate from the DNA after cutting one site in one strand.

SgrAI, on the other hand, behaved differently on a one-site substrate, pAT153, compared with a two-site substrate, pDB7 (Fig. 4). In a reaction buffer containing 50 mM KOAc, SgrAI cleaved its single recognition site on pAT153 in two stages: first in one strand to give OC DNA and only later in the second strand to linearize the DNA (Fig. 4a). Yet, under the same conditions, SgrAI cleaved pDB7 in a highly concerted manner; only small amounts of the OC and FLL forms were released. Instead, the majority of the SC DNA was converted directly to the products cut at both sites, without a detectable lag phase (Fig. 4b). Each turnover of SgrAI on a DNA with one recognition site thus results in the cleavage of one phosphodiester bond, while most of its turnovers on a DNA with two sites result in the cleavage of four phosphodiester bonds. Furthermore, the rate at which SgrAI utilized the two-site substrate (v2A = 1.52 nM·min-1) was faster than the one-site substrate (v1 = 0.32 nM·min-1). The different kinetics of SgrAI on substrates with one or two recognition sites therefore eliminate the possibility that this enzyme acts through independent reactions at individual sites. In addition, while the enhanced reaction rate on pDB7 is consistent with SgrAI being a type IIe enzyme, the lack of accumulation of FLL DNA during this reaction discounts this possibility.


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 4.   SgrAI on plasmids with one or two recognition sites. Reactions at 37 °C contained 50 units·ml-1 SgrAI and 20 nM DNA (~90% supercoiled) in 33 mM Tris acetate (pH 7.9), 10 mM magnesium acetate, 0.5 mM dithiothreitol and either 50 mM KOAc (left panels; a and b) or 200 mM KOAc (right panels; c and d). In the two upper panels (a and c), the DNA was pAT153, which has one SgrAI site. In the two lower panels (b and d), the DNA was pDB7, which has two SgrAI sites. Samples taken from the reactions at timed intervals were analyzed as above to obtain the concentrations of the following forms of the DNA: SC (), OC (), FLL (black-triangle), and total DNA in the two final products cut at both sites (L1/2) (down-triangle; only in b and d).

The 5-fold difference in the rates of the SgrAI reactions on two- and one-site substrates is, however, considerably smaller than the 20-fold difference recorded with SfiI (21, 22). Hence, the diminished yield of FLL DNA during the SgrAI reaction on pDB7 (Fig. 4b) might not be due solely to concerted action at two recognition sites, in the manner of SfiI. Instead, it may be due, at least in part, to processivity along the DNA. The reactions of SgrAI on pAT153 and pDB7 were therefore examined at varied ionic strengths; typical reaction records at an elevated ionic strength are shown in Fig. 4, c and d. In parallel, the reactions of an orthodox enzyme, SgfI, were also examined at varied ionic strengths. SgfI is optimally active in the presence of NaCl, but SgrAI is largely blocked by NaCl (data not shown), so the comparison between SgfI and SgrAI was made by using KOAc to vary the ionic strength. The rates at which SgfI cleaved its two-site and one-site substrates both declined progressively with increasing concentrations of KOAc (data not shown). Nevertheless, the ratio of SgfI activities on the two substrates, v2A/v1, remained at unity at all ionic strengths tested (Fig. 5a). (Similarly, the v2A/v1 ratios for both SrfI and FseI were unaffected by doubling the ionic strengths of their reaction buffers (data not shown).) The rate at which SgrAI utilized its one-site substrate also declined progressively with increasing KOAc concentrations (Fig. 4, a and c). In contrast, the rate at which SgrAI utilized its the two-site substrate remained essentially constant at KOAc concentrations of <= 200 mM (Fig. 4, b and d) and was only reduced at >= 250 mM KOAc. Consequently, the ratio of the reaction rates of SgrAI on its two- and one-site substrates increased from 3 to 30 as the KOAc concentration was raised from 0 to 250 mM (Fig. 5b). The diminished yield of FLL DNA during the SgrAI reaction on pDB7 at 50 mM KOAc (Fig. 4b) therefore cannot be due to processivity.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 5.   Ratio of rates on one- and two-site substrates for SgfI and SgrAI. Reactions at 37 °C contained 50 units·ml-1 restriction endonuclease and 20 nM DNA (with either one or two recognition sites for the enzyme in question) in 33 mM Tris acetate (pH 7.9), 10 mM magnesium acetate, 0.5 mM dithiothreitol, and KOAc at the concentration indicated on the x axis. a, the endonuclease was SgfI, and the one- and two-site substrates were pDB7 and pDB8, respectively. b, the endonuclease was SgrAI, and the one- and two-site substrates were pAT153 and pDB7, respectively. In both cases, initial rates for the utilization of the one-site substrate (v1) and the two-site substrate (v2A) were measured at each concentration of KOAc, and the ratios (v2A/v1) are plotted on the y axis.

At all concentrations of KOAc tested, SgrAI initially cleaved its one-site substrate in just one strand of the DNA to give the OC form (Fig. 4, a and c). However, although the rate of utilization of the two-site substrate for SgrAI remained constant as the KOAc concentration was increased to 200 mM, the initial products from its reactions on pDB7 at high ionic strengths differed from those at low ionic strength. At KOAc concentrations of <= 100 mM, SgrAI cleaved its two-site substrate in a highly concerted manner, converting almost all of the substrate directly to the final products cut in both strands at both sites (as noted above at 50 mM KOAc; Fig. 4b). In contrast, at concentrations of KOAc of >= 125 mM, SgrAI cleaved the two-site substrate in a sequential series of separate reactions, giving first the OC form and then the FLL form and only later L1 and L2 (in all cases, as in Fig. 4d). Like SfiI (22), both the difference between the reaction rates of SgrAI on one- and two-site substrates and the degree of its concertedness on the two-site substrate vary with the ionic strength of the reaction buffer. The behavior of SgrAI on its one- and two-site substrates matches the expectations for a restriction endonuclease that acts concertedly at two recognition sites.

Other Restriction Enzymes with 8-bp Sites-- The MCS in pNEB193 contains single copies of the 8-bp sites for AscI, PacI, PmeI, and Sse8387I (Fig. 1b). A derivative of pNEB193, pAB1, was constructed with two copies of the MCS in inverted orientation (Fig. 1b). On pAB1, the distance between the pairs of recognition sites varied from 717 bp for AscI to 803 bp for Sse8387I. The SC forms of pNEB193 and pAB1 were used as one- and two-site substrates for these enzymes. An isoschizomer of Sse8387I, SdaI (Table I), was also examined in the same manner. Both Sse8387I and SdaI are from Streptomyces species, and they also have in common with SfiI a G:C-rich recognition sequence, as does AscI and all four of the enzymes analyzed above (Table I). The restriction sites that are 8 bp long generally possess a marked preponderance (>= 75%) of either G:C bp or A:T bp (1). PacI and PmeI provide two examples of the latter (Table I).

When assayed on pNEB193 and pAB1, Sse8387I, SdaI, PacI, and PmeI all behaved on the one- and two-site substrates in the same manner as SgfI (see Figs. 2 and 3). All four of these enzymes gave the same rates for the utilization of the one- and the two-site substrates (data not shown). All four cleaved the two-site substrate in sequential stages: first at one site to give FLL DNA and then at the second site to give L1 and L2, with the same rates for the two stages. This behavior was observed in both the standard reaction buffer for the enzyme in question and at elevated ionic strengths. Sse8387I, SdaI, PacI, and PmeI thus all cleave DNA via independent reactions at individual recognition sites in the orthodox manner for type II restriction enzymes.

AscI, however, showed a distinctive pattern of behavior on pAB1 (Fig. 6). Instead of cleaving this two-site substrate in sequential stages, first to FLL DNA and then after a lag phase to L1 and L2, the reaction of AscI on pAB1 at a low ionic strength yielded less of the FLL DNA than expected for a pathway involving two kinetically equal steps. It also yielded the doubly cut products directly from the start of the reaction rather than after a lag phase (Fig. 6a). However, at an elevated ionic strength, the reaction profile for AscI on its two-site substrate conformed to the expectations for a two-step sequential pathway, since it now gave rise first to FLL DNA and only later, after a lag phase, the doubly cut products (Fig. 6b).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 6.   AscI on a plasmid with two recognition sites. Reactions at 37 °C contained 24 units·ml-1 AscI and 10 nM pAB1 (~90% supercoiled) in 20 mM Tris acetate (pH 7.9), 10 mM magnesium acetate, 1 mM dithiothreitol, 100 µg/ml bovine serum albumin, and either 20 mM KOAc (a) or 200 mM KOAc (b). Samples taken from the reactions at timed intervals were analyzed as above to obtain the concentrations of the following forms of the DNA: SC (), OC (), FLL (black-triangle), and total DNA in the two final products cut at both sites (L1/2; down-triangle).

The reaction of AscI on pAB1 at low ionic strength (Fig. 6a) is consistent with a value for v2B, the rate for cutting the FLL DNA to L1 and L2, at twice that for v2A, the rate for converting the SC substrate to FLL DNA. A possible reason for this enhancement of v2B over v2A could be that AscI is more active on linear DNA than on SC DNA, but this was discounted. Linear DNA substrates were cleaved by AscI at the same rate as SC substrates (data not shown). Moreover, the data at the elevated ionic strength (Fig. 6b) is consistent with a value for v2B that is only 1.2 times higher that that for v2A. In addition, the rates at which AscI utilized its one-site substrate, pNEB193, were the same as those for its two-site substrate, pAB1; at 20 mM KOAc, v1 = 0.52 nM·min-1 and v2A = 0.51 nM·min-1.

The diminished yield of FLL DNA during the reactions of AscI on its two-site substrate at low strength is therefore not due to concerted action at two recognition sites in the manner of SfiI. Instead, AscI appears to be capable of a high degree of processivity between two recognition sites, even when these are separated by 717 bp. At low ionic strength, AscI presumably binds to one recognition site, cleaves the DNA at that site, and then translocates to the second site by an intramolecular process, without leaving the DNA. One turnover of the enzyme can then result in the cleavage of two separate sites on the DNA. Similar transfers between recognition sites were noted previously with EcoRI (12, 13) although over shorter distances than those recorded here with AscI. However, as with EcoRI, processivity by AscI is abolished by raising the ionic strength.

Streptomyces Restriction Enzymes-- Two enzymes that act concertedly at 8-bp recognition sites are SfiI (23) and SgrAI (this study), which both originate from Streptomyces species. To determine whether concerted action at two sites is a common feature of Streptomyces restriction enzymes, some endonucleases from Streptomyces species that have 6-bp recognition sites were examined by the above procedure. The MCS on pNEB193 has single sites for three such enzymes, SacI, SalI, and SphI (Table I), so pAB1 carries two copies of these recognition sequences (Fig. 1b). Previous studies on the kinetics of DNA cleavage by SalI (46) had only used substrates with one recognition site, thus leaving open the possibility that SalI would display enhanced activity on a DNA with two sites. No studies on the kinetics of SacI and SphI have been reported to date. However, SalI, SacI, and SphI all displayed the same activity on the one-site substrate, pNEB193, and the two site-substrate, pAB1, and they all cleaved the latter by means of independent reactions at individual sites (data not shown).

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Type II restriction enzymes are, conventionally, dimeric proteins that cleave DNA at individual sites (11), but SfiI is a tetramer that cleaves DNA only after binding to two copies of its recognition sequence (25). When the mechanism of SfiI was first characterized (21), no other type II enzyme was known to operate in this manner. SfiI is distinct from the type IIe enzymes such as EcoRII and NaeI (24). It carries out concurrent DNA cleavage reactions at two identical binding sites for its cognate DNA (23, 27), whereas the type IIe enzymes seem to have two dissimilar binding sites, with the DNA at one site acting solely as an activator for catalysis at the other site (15-18). In this study, a screen was developed to search for other endonucleases that require two sites for their catalytic reactions. The kinetics of a restriction enzyme on plasmids that have either one or two recognition sites for the enzyme were shown to provide a clear cut distinction between the following schemes: separate reactions at individual sites; processivity by translocation from one site to another without leaving the DNA; activation by a second copy of the recognition sequence, as in the type IIe systems; and concerted action at two recognition sites, like SfiI. The test was applied to 12 different endonucleases that recognize 8-bp sequences and/or come from Streptomyces species in the belief that these would be the most likely to act like SfiI.

Ten of the enzymes behaved in the conventional manner and cleaved individual sites in independent reactions. These included several Streptomyces enzymes that recognize either 8-bp sequences (SgfI, SrfI, Sse8387I, and SdaI) or 6-bp sequences (SacI, SalI, and SphI). The Streptomyces enzymes that recognize 8-bp sites all act at G:C-rich sequences (Table I), but conventional behavior was also observed with other enzymes whose 8-bp sites are either G:C-rich, such as FseI, or A:T-rich, such as PacI and PmeI. Concerted action at two recognition sites is clearly not a universal feature of the restriction enzymes that recognize 8-bp sequences nor of those from Streptomyces species. However, two enzymes deviated from the conventional pattern. In one case, AscI, the cleavage of the two-site substrate matched the expectation for a processive enzyme, at least at low ionic strength (Fig. 6a). The translocation of an enzyme from one specific site to another must involve a succession of transient associations with nonspecific DNA. Perhaps AscI dissociates from nonspecific DNA at a slower rate than the other enzymes tested here. The other exception, SgrAI, showed the pattern expected for an enzyme acting concertedly at two recognition sites. None of the 12 enzymes followed the pathway proposed for the type IIe enzymes.

The kinetics of SgrAI on one-site and two-site substrates show that this enzyme needs two sites for optimal activity. On a DNA with one site, SgrAI presumably acts in trans, bridging sites on separate molecules, but the resultant complex has too short a lifetime to allow the enzyme to cleave more than one phosphodiester bond before it breaks down (Fig. 4a). On a DNA with two sites, SgrAI would act preferentially in cis, looping out the DNA between two sites on the same molecule. At low ionic strength, the lifetime of the complex with sites in cis is long enough to allow the enzyme to cut both strands at both sites before it falls apart (Fig. 4b). The looped complex is likely to have a shorter lifetime at high ionic strength so that the enzyme then has only enough time to cut one phosphodiester bond (Fig. 4d). Nevertheless, as expected given the relative stabilities of DNA-protein complexes in cis over those in trans (28), elevated ionic strengths reduced SgrAI activity on the one-site DNA more severely than that on the two-site DNA (Fig. 5). In these respects, SgrAI behaves like SfiI (22). However, while the ability of SgrAI to cleave four phosphodiester bonds in one turnover suggests a tetrameric structure, this has yet to be established. In further experiments on SgrAI,2 the ratio of its activities on two- and one-site DNA increased with increasing concentrations of the protein, thus raising the possibility that SgrAI may exist as an inactive dimer and that two DNA-bound dimers associate to form an active tetramer.

The recognition sequence for SfiI contains a 5-bp interruption amid 8 specified bp and thus covers 13 bp, longer than is usual for a restriction site (Ref. 33; Table I). Hence, it has been suggested that SfiI is a special case among restriction enzymes and that its unusual reaction mechanism is due to the length of its recognition site (47). However, the recognition site for SgrAI is a continuous sequence of 8 bp. Moreover, it has recently been found that Cfr10I, an enzyme that recognizes a continuous sequence of 6 bp, operates in exactly the same way as SfiI (47). Like SfiI (21, 25), Cfr10I is a tetramer instead of the dimer proposed previously (48). Again, like SfiI (23, 26), Cfr10I interacts with two sites to loop out the intervening DNA (47). The requirement of SfiI for two recognition sites is therefore not a consequence of either the length or the discontinuity of its recognition site but is instead due to a mechanism that now appears to be widespread among type II restriction enzymes. Strikingly, the recognition sequence for Cfr10I is the central 6 bp of the 8-bp site for SgrAI. Different restriction enzymes often follow similar reaction mechanisms (e.g. EcoRV and TaqI) (7, 10). The similarities in mechanism have not, however, been accompanied previously by similarities in recognition sequence.

Endonucleases that need two recognition sites might seem to be less suited for restriction in vivo than enzymes acting at a single site, especially with 8-bp sites. In a random sequence containing equal amounts of A, T, G, and C, an 8-bp sequence occurs statistically once per 66 kb (for the degenerate SgrAI site (Table I), once per 16 kb). When 2 megabase pairs of Streptomyces coelicolor DNA was analyzed for restriction sites for the Streptomyces enzymes that recognize 8-bp sequences (30), the sites for several of the enzymes occurred at frequencies close to the statistical expectation. But interestingly, the enzymes whose 8-bp sites occur most frequently in this DNA are those that need two sites for their reactions, namely SgrAI and SfiI. Recognition sites for SgrAI and SfiI were found in S. coelicolor DNA at mean intervals of 1.3 and 2.7 kb, respectively (30). Thus, while SgrAI and SfiI sites may be rare in DNA from other species, they are remarkably common in Streptomyces DNA. If the DNA targets for restriction in vivo by SgrAI or SfiI are as rich in these sites as S. coelicolor DNA, then the enzymes would have no difficulty in locating two sites on the target and restricting it. In addition to these type II enzymes, many other restriction systems employ endonucleases that require two sites on the target DNA: the type III systems (49), some methylation-specific systems (50), and, in some situations, the type I systems (51). The reason why SfiI interacts with two recognition sites is to ensure that it cleaves DNA only at its cognate sequence. It cannot form synaptic complexes with noncognate DNA or with one cognate and one noncognate site, and only the synaptic complex with two cognate sites is catalytically active (27). The same rationale may apply to SgrAI and to Cfr10I.

Of the 10 restriction enzymes with 8-bp sites analyzed here and in previous studies (21), only SfiI and SgrAI were found to act concertedly at two copies of their recognition sequences. Hence, it might seem that concerted action at two sites is relatively uncommon among these enzymes, but this may not be so. Almost all restriction enzymes identified to date were discovered by assaying cell-free extracts of bacterial cultures for the fragmentation of a test DNA, usually phage lambda  or adenoviral DNA (11). However, if an endonuclease needs two copies of an 8-bp sequence separated by an appropriate length of DNA, the test DNA may not be a substrate. For example, there are no SfiI sites on phage lambda  DNA, and the SfiI endonuclease was discovered by assaying extracts from S. fimbriatus on adenoviral DNA (33). Fortuitously, adenoviral DNA contains two SfiI sites separated by 1 kb, which is close enough for a looping reaction by SfiI on linear DNA (22). If the SfiI sites on this DNA had been separated by >10 kb, it is unlikely that its activity would have been detected. Hence, concerted action at two DNA sites may be a common feature of the type II restriction endonucleases present in nature but which have yet to be discovered by in vitro assays.

    ACKNOWLEDGEMENTS

We thank Niall Gormley, Humin Kong, Susan Milsom, Ira Schildkraut, Virginijus Siksnys, Mark Szczelkun, and Mark Watson for aid and advice.

    FOOTNOTES

* This work was supported by grants from the Wellcome Trust and the Biotechnology and Biological Sciences Research Council.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Dept. of Biochemistry, School of Medical Sciences, University of Bristol, University Walk, Bristol BS8 1TD, UK. Tel.: 44-117-928-7429; Fax: 44-117-928-8274; E-mail: s.halford@bris.ac.uk.

2 L. E. Daniels and S. E. Halford, manuscript in preparation.

    ABBREVIATIONS

The abbreviations used are: bp, base pair; kb, kilobase pair(s); MCS, multiple cloning site; SC, supercoiled; OC, open circle; FFL, full-length linear; L1 and L2, linear DNA fragments from the cleavage of a circular DNA with two sites at both sites.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Roberts, R. J., and Macelis, D. (1999) Nucleic Acids Res. 26, 312-313
2. Qiang, B-Q., and Schildkraut, I. (1987) Methods Enzymol. 155, 15-21[Medline] [Order article via Infotrieve]
3. Naito, T., Kusano, K., and Kobayashi, I. (1995) Science 267, 897-899[Abstract/Free Full Text]
4. Wilson, G. G., and Murray, N. E. (1991) Annu. Rev. Genet. 19, 585-627[CrossRef]
5. Kobayashi, I. (1996) in Epigenetic Mechanisms of Gene Regulation (Russo, V. , Martienssen, R. , and Riggs, A., eds) , pp. 155-172, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
6. Dorner, L. F., Bitinaite, J., Whitaker, R. D., and Schildkraut, I. (1999) J. Mol. Biol. 285, 1515-1523[CrossRef][Medline] [Order article via Infotrieve]
7. Baldwin, G. S., Sessions, R. B., Erskine, S. G., and Halford, S. E. (1999) J. Mol Biol. 288, 87-104[CrossRef][Medline] [Order article via Infotrieve]
8. Sasnauskas, G., Jeltsch, A, Pingoud, A., and Siksnys, V. (1999) Biochemistry 38, 4028-4036[CrossRef][Medline] [Order article via Infotrieve]
9. Horton, J. R., Nastri, H. G., Riggs, P. D., and Cheng, X. (1998) J. Mol. Biol. 284, 1491-1504[CrossRef][Medline] [Order article via Infotrieve]
10. Cao, W. (1999) Biochemistry 38, 8080-8087[CrossRef][Medline] [Order article via Infotrieve]
11. Roberts, R. J., and Halford, S. E. (1993) in Nucleases (Linn, S. M. , Lloyd, R. S. , and Roberts, R. J., eds) , pp. 35-88, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
12. Terry, B. J., Jack, W. E., and Modrich, P. (1985) J. Biol. Chem. 260, 13130-13137[Abstract/Free Full Text]
13. Terry, B. J., Jack, W. E., and Modrich, P. (1987) Gene Amplif. Anal. 5, 103-118[Medline] [Order article via Infotrieve]
14. Krüger, D. H., Barcak, G. J., Reuter, M., and Smith, H. O. (1988) Nucleic Acids Res. 16, 3997-4008[Abstract/Free Full Text]
15. Yang, C. C., and Topal, M. D. (1992) Biochemistry 31, 9657-9664[CrossRef][Medline] [Order article via Infotrieve]
16. Gabbara, S., and Bhagwat, A. S. (1992) J. Biol. Chem. 267, 18623-18630[Abstract/Free Full Text]
17. Baxter, B. K., and Topal, M. D. (1993) Biochemistry 32, 8291-8298[CrossRef][Medline] [Order article via Infotrieve]
18. Reuter, M., Kupper, D., Meisel, A., Schroeder, C., and Krüger, D. H. (1998) J. Biol. Chem. 273, 8294-8300[Abstract/Free Full Text]
19. Pein, C-D., Reuter, M., Meisel, A., Cech, D., and Krüger, D. H. (1991) Nucleic Acids Res. 19, 5139-5142[Abstract/Free Full Text]
20. Conrad, M., and Topal, M. D. (1992) Nucleic Acids Res. 20, 5127-5130[Abstract/Free Full Text]
21. Wentzell, L. M., Nobbs, T. J., and Halford, S. E. (1995) J. Mol. Biol. 248, 581-595[CrossRef][Medline] [Order article via Infotrieve]
22. Nobbs, T. J., and Halford, S. E. (1995) J. Mol. Biol. 252, 399-411[CrossRef][Medline] [Order article via Infotrieve]
23. Szczelkun, M. D., and Halford, S. E. (1996) EMBO J. 15, 1460-1469[Medline] [Order article via Infotrieve]
24. Nobbs, T. J., Williams, S. A., Connolly, B. A., and Halford, S. E. (1998) Biol. chem. 379, 599-604[Medline] [Order article via Infotrieve]
25. Nobbs, T. J., Szczelkun, M. D., Wentzell, L. M., and Halford, S. E. (1998) J. Mol. Biol. 281, 419-432[CrossRef][Medline] [Order article via Infotrieve]
26. Wentzell, L. M., and Halford, S. E. (1998) J. Mol. Biol. 281, 433-444[CrossRef][Medline] [Order article via Infotrieve]
27. Embleton, M. L., Williams, S. A., Watson, M. A., and Halford, S. E. (1999) J. Mol. Biol. 289, 785-797[CrossRef][Medline] [Order article via Infotrieve]
28. Rippe, K., von Hippel, P. H., and Langowski, J. (1995) Trends Biochem. Sci. 20, 500-506[CrossRef][Medline] [Order article via Infotrieve]
29. Hallet, B., and Sherratt, D. J. (1997) FEMS Microbiol. Rev. 21, 157-178[CrossRef][Medline] [Order article via Infotrieve]
30. Bilcock, D. T., and Halford, S. E. (1999) Mol. Microbiol. 31, 1243-1254[CrossRef][Medline] [Order article via Infotrieve]
31. Grasby, J. A., and Connolly, B. A. (1992) Biochemistry 31, 7855-7861[CrossRef][Medline] [Order article via Infotrieve]
32. Mizuuchi, K., Nobbs, T. J., Halford, S. E., Adzuma, K., and Qin, J. (1999) Biochemistry 38, 4640-4648[CrossRef][Medline] [Order article via Infotrieve]
33. Qiang, B-Q., and Schildkraut, I. (1984) Nucleic Acids Res. 12, 4507-4516[Abstract/Free Full Text]
34. Twigg, A. J., and Sherratt, D. J. (1980) Nature 283, 216-218[CrossRef][Medline] [Order article via Infotrieve]
35. Yanisch-Perron, C., Viera, C., and Messing, J. (1985) Gene (Amst.) 33, 103-119[CrossRef][Medline] [Order article via Infotrieve]
36. Sambrook, J. C., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
37. Kelleher, J. E., and Raleigh, E. A. (1994) J. Bacteriol. 176, 5888-5896[Abstract/Free Full Text]
38. Halford, S. E., Taylor, J. D., Vermote, C. L. M., and Vipond, I. B. (1994) Methods Mol. Biol. 30, 385-396[Medline] [Order article via Infotrieve]
39. Erskine, S. G., Baldwin, G. S., and Halford, S. E. (1997) Biochemistry 36, 7567-7576[CrossRef][Medline] [Order article via Infotrieve]
40. Gutfreund, H. (1995) Kinetics for the Life Sciences , Cambridge University Press, Cambridge, UK
41. Thomas, M., and Davis, R. W. (1975) J. Mol. Biol. 91, 314-328
42. Halford, S. E., Johnson, N. P., and Grinsted, J. (1980) Biochem. J. 191, 581-592[Medline] [Order article via Infotrieve]
43. Taylor, J. D., and Halford, S. E. (1992) Biochemistry 28, 6198-6207
44. Oram, M., Marko, J. F., and Halford, S. E. (1997) J. Mol. Biol. 270, 396-412[CrossRef][Medline] [Order article via Infotrieve]
45. Jian, H., Schlick, T., and Vologodskii, A. (1998) J. Mol. Biol. 284, 287-296[CrossRef][Medline] [Order article via Infotrieve]
46. Maxwell, A., and Halford, S. E. (1980) Biochem. J. 203, 85-92
47. Siksnys, V., Skirgaila, R., Sasnauskas, G., Urbanke, C., Cherny, D., Grazulis, S., and Huber, R. (1999) J. Mol. Biol. 291, 1105-1118[CrossRef][Medline] [Order article via Infotrieve]
48. Bozic, D., Grazulis, S., Siksnys, V., and Huber, R. (1996) J. Mol. Biol. 255, 176-186[CrossRef][Medline] [Order article via Infotrieve]
49. Meisel, A., Bickle, T. A., Krüger, D. H., and Schroeder, C. (1992) Nature 355, 467-469[CrossRef][Medline] [Order article via Infotrieve]
50. Penne, D., Raleigh, E. A., and Bickle, T. A. (1999) J. Mol. Biol. 290, 49-60[CrossRef][Medline] [Order article via Infotrieve]
51. Szczelkun, M. D., Dillingham, M. S., Janscak, P., Firman, K., and Halford, S. E. (1996) EMBO J. 15, 6335-6347[Medline] [Order article via Infotrieve]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. R. Coffin and N. O. Reich
Escherichia coli DNA Adenine Methyltransferase: THE STRUCTURAL BASIS OF PROCESSIVE CATALYSIS AND INDIRECT READ-OUT
J. Biol. Chem., July 3, 2009; 284(27): 18390 - 18400.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
P. W. Dunten, E. J. Little, M. T. Gregory, V. M. Manohar, M. Dalton, D. Hough, J. Bitinaite, and N. C. Horton
The structure of SgrAI bound to DNA; recognition of an 8 base pair target
Nucleic Acids Res., September 1, 2008; 36(16): 5405 - 5416.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
E. Sisakova, L. K. Stanley, M. Weiserova, and M. D. Szczelkun
A RecB-family nuclease motif in the Type I restriction endonuclease EcoR124I
Nucleic Acids Res., July 1, 2008; 36(12): 3939 - 3949.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. J. Gemmen, R. Millin, and D. E. Smith
Tension-dependent DNA cleavage by restriction endonucleases: Two-site enzymes are "switched off" at low force
PNAS, August 1, 2006; 103(31): 11555 - 11560.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
G. J. Gemmen, R. Millin, and D. E. Smith
DNA looping by two-site restriction endonucleases: heterogeneous probability distributions for loop size and unbinding force
Nucleic Acids Res., May 24, 2006; 34(10): 2864 - 2877.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
D. M. Gowers, S. R.W. Bellamy, and S. E. Halford
One recognition sequence, seven restriction enzymes, five reaction mechanisms
Nucleic Acids Res., June 29, 2004; 32(11): 3469 - 3479.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Hingorani-Varma and J. Bitinaite
Kinetic Analysis of the Coordinated Interaction of SgrAI Restriction Endonuclease with Different DNA Targets
J. Biol. Chem., October 10, 2003; 278(41): 40392 - 40399.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. J. Bath, S. E. Milsom, N. A. Gormley, and S. E. Halford
Many Type IIs Restriction Endonucleases Interact with Two Recognition Sites before Cleaving DNA
J. Biol. Chem., February 1, 2002; 277(6): 4024 - 4033.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. A. Gormley, A. L. Hillberg, and S. E. Halford
The Type IIs Restriction Endonuclease BspMI Is a Tetramer That Acts Concertedly at Two Copies of an Asymmetric DNA Sequence
J. Biol. Chem., February 1, 2002; 277(6): 4034 - 4041.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Bitinaite and I. Schildkraut
Self-generated DNA termini relax the specificity of SgrAI restriction endonuclease
PNAS, January 24, 2002; (2002) 22346799.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
A. Pingoud and A. Jeltsch
Structure and function of type II restriction endonucleases
Nucleic Acids Res., September 15, 2001; 29(18): 3705 - 3727.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. A. Gormley, A. J. Bath, and S. E. Halford
Reactions of BglI and Other Type II Restriction Endonucleases with Discontinuous Recognition Sites
J. Biol. Chem., March 15, 2000; 275(10): 6928 - 6936.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Friedhoff, R. Lurz, G. Luder, and A. Pingoud
Sau3AI, a Monomeric Type II Restriction Endonuclease That Dimerizes on the DNA and Thereby Induces DNA Loops
J. Biol. Chem., June 22, 2001; 276(26): 23581 - 23588.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Soundararajan, Z. Chang, R. D. Morgan, P. Heslop, and B. A. Connolly
DNA Binding and Recognition by the IIs Restriction Endonuclease MboII
J. Biol. Chem., January 4, 2002; 277(2): 887 - 895.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Bitinaite and I. Schildkraut
Self-generated DNA termini relax the specificity of SgrAI restriction endonuclease
PNAS, February 5, 2002; 99(3): 1164 - 1169.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bilcock, D. T.
Right arrow Articles by Halford, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bilcock, D. T.
Right arrow Articles by Halford, S. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement